FDA commissioner's vision: Time to revamp the evidence generation system
With an eye toward finishing out President Biden’s first term in office, FDA commissioner Rob Califf said Tuesday afternoon that he’ll seek to address (on top of the infant formula and food-related fiascos) misinformation and creating new ways to bolster the wider evidence generation system that the agency relies on to make approval decisions.
While referring to the FDA as both a “decision-making machine” and “in essence, a referee that plays by a set of rules,” Califf made clear that his second stint as FDA commissioner will be focused more on the embrace of new data, perhaps harkening back to his recent work with Google’s parent company Alphabet, where he led the firm’s health strategy and policy side.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.